EVITRADE Announces Amendment to Artillery Labs Acquisition
ACCESSWIRE 29-Oct-2018 11:31 PM
VANCOUVER, BC /ACCESSWIRE / October 29, 2018 / EVITRADE HealthSystems Corp. (CSE:EVA, OTCQB:EVAHF) (the "Company" or "Evitrade") is pleasedto announce that, further to its press release dated April 30, 2018, that ithas signed an amending agreement for the acquisition of ArtilleryHoldings Ltd.(DBA Artillery Labs) ("Artillery").
Pursuant to the definitiveagreement Evitrade was to acquire all of the issued and outstanding common sharesof Artillery in for an aggregate of 5 million common shares of Evitrade.Instead the Company will now enter into aPlan of Arrangement with Artillery and an Evitrade subsidiary to assist with Artillery's development and its focus on marketing of health andwellness products.
In conjunction with the amending agreement Evitrade will beassigned a $100,000 USD convertible note that it has acquired from a boutiqueinvestment and financing company as part of the amending settlement agreementfor 450,000 shares issued at a deemed price of $.30 and the cancellation of thebalance of the 5 million shares held for the closing of the transaction.
Management of Evitrade believes the acquisition will further continueto enhance Evitrade's business and commercialization strategies.
For more information, please contact:
C.K. Cheung, CEO & Director
EVITRADE Health Systems Corporation
Email info@evahealthsystems.com
Website http://www.evahealthsystems.com
CSE Micro-site: http://thecse.com/en/listings/technology/evitrade-health-systems-corp US OTC Markets (OTCQB): http://www.otcmarkets.com/stock/EVAHF/news
About EVITRADE Health (CSE:EVA, OTCQB:EVAHF)
EVITRADE Health Systems Corp. (formerly AuxellenceHealth Corp.), is a Technology company specializing in the Life Sciences sectorlooking to deliver effective health solutions with a higher degree ofpredictability and consistency. The Company is focused in four main areas, Autonomous MedicalCare, Molecular Biology, Nutraceutical Solutions and Genetic Selection. Throughits Focus on Autonomous Medical Care, the Company offers a physiologicallyinteractive computing platform that integrates medical devices and artificialintelligence applications into a fully automated, personal health managementsystem for various chronic conditions.
AboutArtillery
Artillery has beenactive in the online marketing various health and wellness products since 2015. In addition to its varied andencompassing digital marketing capabilities, Artillery has a portfolio ofbrands that it has developed and been successful with over the past severalyears.
Forward Looking Statements;Disclaimers
This newsrelease contains forward-looking statements based on assumptions and judgmentsof management regarding future events or results. Such statements are subjectto a variety of risks and uncertainties which could cause actual events orresults to differ materially from those reflected in the forward lookingstatements. The Company disclaims any intention or obligation to revise orupdate such statements. For a description of the risks and uncertainties facingthe Company and its business and affairs, readers should refer to the Company'sManagement's Discussion and Analysis and other disclosure filings with Canadiansecurities regulators and on the OTC Markets website which are posted on www.sedar.com, http://thecse.com/en/listings/technology/evitrade-health-systems-corp, and https://www.otcmarkets.com/stock/EVAHF/news,respectively. This news release does not constitute an offer to sell orsolicitation of an offer to buy any of the securities described herein andaccordingly undue reliance should not be put on such. Neither the CanadianSecurities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider(as that term is defined in policies of the CSE), or any other regulatoryauthority accepts responsibility for the adequacy or accuracy of this release.The Company does not undertake to update this news release unless required byapplicable law.
This newsrelease does not constitute an offer to sell or a solicitation of an offer tobuy any of the securities described herein in the United States. The securitiesdescribed herein have not been registered under the United States SecuritiesAct of 1933, as amended (the "U.S. Securities Act"), or any state securitieslaw and may not be offered or sold in the "United States", as such term is definedin Regulation S promulgated under the U.S. Securities Act, unless registeredunder the U.S. Securities Act and applicable state securities laws or anexemption from such registration requirements is available.
SOURCE: EVITRADE HealthSystems Corp.
